Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Dr. Yinying Lu: Close Relationship Between Gut Microbiota and Hepatobiliary Tumors

    1. The Close Relationship Between Gut Microecology and Tumor Occurrence The gut microbiota is closely related to human health and the occurrence of diseases. A balanced gut microecology helps maintain…

    2024.09.09
  • Alerting Liver Damage Caused by Lead Poisoning Accompanied by Abdominal Pain and Anemia: Diagnostic and Treatment Approach of a Rare Case

    Authors: Liang Zhang, Jianping Qin, Shanhong Tang Institution: Department of Gastroenterology, General Hospital of Western Theater Command Thematic Review Lead is a toxic heavy metal primarily absorbed through the respiratory…

    2024.09.08
  • Dr. Jie Li: Exploring and Prospects of Functional Cure for Chronic Hepatitis B

    1. HBsAg Clearance Significantly Reduces the Risk of HCC and End-Stage Liver Disease in CHB Patients A study in Chinese Taiwan recruited patients with CHB-related liver cirrhosis who achieved virological…

    2024.09.08
  • Can Expired Blood Culture Bottles Still Be Used?

    In resource-limited settings, the use of medical equipment is often restricted by expiration dates and storage conditions. However, new research conducted by the Institute of Tropical Medicine (ITM) in Antwerp,…

    2024.09.08
  • Dr. Yue Lu: A Review and Update on Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

    Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), a rare malignancy of the hematopoietic system, is distinguished by its highly recognizable skin manifestations and complex pathophysiology, which continue to captivate the medical community’s investigative spirit and challenge its resolve. Recently, Dr. Yue Lu from Lu Daopei Medical provided an in-depth analysis of BPDCN’s origins, clinical presentation, diagnostic…

    2024.09.08
  • Mutual Learning Between China and Germany丨International Perspectives, Leading the Frontier: The Academic Journey of Dr. Jürgen Wolf from the Universit

    With an international perspective and a focus on leading-edge advancements, the Overseas Experts China Tour project welcomed a prominent figure in the field of lung cancer from August 5th to 10th, 2024—Dr. Jürgen Wolf, Director of the Centre for Integrated Oncology (CIO) at University Hospital of Cologne, Professor of Interdisciplinary Translational Oncology at the University…

    2024.09.08
  • Dr. Zhizhong Pan: The Journey of Colorectal Cancer Immunotherapy Research—Experiences from Sun Yat-sen University Cancer Center丨Guangzhou Colorectal Cancer Summit Forum

    At the Guangzhou Colorectal Cancer Summit Forum and the 22nd Guangdong Colorectal Cancer Academic Conference held from August 5-10, 2024, Dr. Zhizhong Pan from Sun Yat-sen University Cancer Center delivered an insightful presentation titled “The Journey of Colorectal Cancer Immunotherapy Research: Experiences from Sun Yat-sen University Cancer Center.” After the conference, Professor Pan granted us…

    2024.09.08
  • Insights from Hematology Expert | Dr. Jianxiang Wang: Delving into Immune Mechanisms to Pioneer New Target Frontiers

    The breakthrough achievements of CAR-T therapy in the field of hematologic malignancies are remarkable. However, challenges such as target limitations, limited cell sources, and durability of efficacy continue to necessitate further exploration. Dr. Jianxiang Wang’s team at the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences , stands as a pioneer…

    2024.09.05
«previous next»
Recent Posts
  • Professor Yige Bao: From “New Leaves Spur the Old” to “One Mountain Opens, Another Blocks the Way” —Reflections and Challenges in Post-Neoadjuvant Management of MIBC
  • ESMO Hot Topic Focus | Professor Richard S. Finn: Immunotherapy-Based Combinations Turn “Stone into Gold” — The TALENTOP Study Reshapes the Treatment Landscape of Advanced HCC
  • ESMO International Perspective | Professor Maria Reig: Large International Multicenter Evidence Supports the Inclusion of EBRT in the BCLC Staging and Treatment Algorithm
  • ESMO International Perspective | 42-Month Long-Term Follow-Up with Median OS of 22.8 Months: Professor Manon Allaire Interprets the Outstanding Real-World Performance of the “T+A” Regimen
  • ESMO International Perspective | Global Lung Cancer Experts Discuss the OptiTROP-Lung04 Study: Sacituzumab Tirumotecan Breaks Through Post-TKI Resistance
Recent Comments
    Archives
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top